Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
1-Minute Consult

What is the role for terlipressin in hepatorenal syndrome?

Stephanie N. Bass, PharmD, Aanchal Kapoor, MD and Christina C. Lindenmeyer, MD
Cleveland Clinic Journal of Medicine November 2023, 90 (11) 664-667; DOI: https://doi.org/10.3949/ccjm.90a.23037
Stephanie N. Bass
Department of Pharmacy, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Aanchal Kapoor
Department of Critical Care Medicine, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Find this author on Cleveland Clinic
Christina C. Lindenmeyer
Department of Gastroenterology, Hepatology, and Nutrition, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Find this author on Cleveland Clinic
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Guide to terlipressin dosing.

    Based on information in reference 7.

Tables

  • Figures
    • View popup
    TABLE 1

    Diagnostic criteria for hepatorenal syndrome with acute kidney injury

    Cirrhosis; acute liver failure; ACLF
    Increase in serum creatinine:
    • ≥ 0.3 mg/dL within 48 hours or

    • ≥ 50% from baseline according to ICA criteria and/or

    • Urinary output ≤ 0.5 mL/kg ≥ 6 hours.

    No full or partial response after at least 2 days of diuretic withdrawal and volume expansion with albumin (1 g/kg body weight per day to a maximum 100 g/day)
    Absence of shock
    No current or recent treatment with nephrotoxic drugs
    Absence of parenchymal disease as indicated by proteinuria > 500 mg/day, microhematuria and/or abnormal renal ultrasonography
    • ACLF = acute-on-chronic liver failure

    • Reprinted from J Hepatol 2019; 71(4):811–822. doi:10.1016/j.ep.2019.07.002. Angeli P, Garcia-Tsao G, Nadim MK, Parikh CR.

    • News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document, with permission from Elsevier.

PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 90 (11)
Cleveland Clinic Journal of Medicine
Vol. 90, Issue 11
1 Nov 2023
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
What is the role for terlipressin in hepatorenal syndrome?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
What is the role for terlipressin in hepatorenal syndrome?
Stephanie N. Bass, Aanchal Kapoor, Christina C. Lindenmeyer
Cleveland Clinic Journal of Medicine Nov 2023, 90 (11) 664-667; DOI: 10.3949/ccjm.90a.23037

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
What is the role for terlipressin in hepatorenal syndrome?
Stephanie N. Bass, Aanchal Kapoor, Christina C. Lindenmeyer
Cleveland Clinic Journal of Medicine Nov 2023, 90 (11) 664-667; DOI: 10.3949/ccjm.90a.23037
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • HEPATORENAL SYNDROME: UPDATED DEFINITIONS
    • TERLIPRESSIN: THE ONLY APPROVED THERAPY FOR HRS-AKI
    • EVIDENCE FOR TERLIPRESSIN
    • PATIENT SELECTION CONSIDERATIONS: POPULATIONS AT RISK OF ADVERSE EFFECTS
    • THE BOTTOM LINE
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

1-Minute Consult

  • My adult patient’s hypercholesterolemia is not responding to statins—what’s next?
  • Should I start anticoagulation in my patient newly diagnosed with pulmonary hypertension?
  • What diagnostic tests should be done after discovering clubbing in a patient without cardiopulmonary symptoms?
Show more 1-Minute Consult

Hepatology

  • Anchors away
  • Cirrhosis: Primary care approaches to screening, immunization, and lifestyle modifications
Show more Hepatology

Nephrology

  • Anchors away
  • Cirrhosis: Primary care approaches to screening, immunization, and lifestyle modifications
  • What is the role for terlipressin in hepatorenal syndrome?
Show more Nephrology

Critical-Care

  • Anchors away
  • Cirrhosis: Primary care approaches to screening, immunization, and lifestyle modifications
  • What is the role for terlipressin in hepatorenal syndrome?
Show more Critical-Care

Similar Articles

Subjects

  • Critical Care
  • Hepatology
  • Nephrology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire